1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cholestasis, Intrahepatic

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cholestasis, Intrahepatic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Birke, F; Jamieson, N; Meade, CJ; Metcalfe, S; Neild, G; Watson, C	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cholestasis, Intrahepatic

Article	Year
Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation. Journal of lipid mediators and cell signalling, 1994, Volume: 9, Issue:3 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Cholestasis, Intrahepatic; Female; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Liver; Liver Transplantation; Male; Nephrectomy; Phospholipases A; Platelet Activating Factor; Reference Values; Reproducibility of Results	1994

Article

Year

Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation.

Journal of lipid mediators and cell signalling, 1994, Volume: 9, Issue:3

Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Cholestasis, Intrahepatic; Female; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Liver; Liver Transplantation; Male; Nephrectomy; Phospholipases A; Platelet Activating Factor; Reference Values; Reproducibility of Results

1994